Concentra Chief Medical Officer John Anderson retires effective Dec. 31, 2026

Concentra Group Holdings Parent announced that Executive Vice President and Chief Medical Officer John R. Anderson will retire effective December 31, 2026. Following his retirement, Anderson will enter a consulting agreement with the company's Concentra Health Services unit, starting January 1, 2027, through December 31, 2027. In this part-time role, he will provide support focused on clinical strategy, medical affairs, and regulatory matters. The engagement allows either party to terminate it with 30 days' written notice.

Concentra Group Holdings Parent disclosed that Executive Vice President and Chief Medical Officer John R. Anderson will retire effective Dec. 31, 2026. * Its Concentra Health Services unit signed a consulting agreement with Anderson on July 6, 2026, effective Jan. 1, 2027 through Dec. 31, 2027. * Anderson is set to provide part-time support focused on clinical strategy, medical affairs, regulatory matters. * The arrangement allows either side to end the engagement with 30 days’ written notice. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concentra Group Holdings Parent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002014596-26-000047), on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Concentra Group Holdings Parent disclosed that Executive Vice President and Chief Medical Officer John R. Anderson will retire effective Dec. 31, 2026. * Its Concentra Health Services unit signed a consulting agreement with Anderson on July 6, 2026, effective Jan. 1, 2027 through Dec. 31, 2027. * Anderson is set to provide part-time support focused on clinical strategy, medical affairs, regulatory matters. * The arrangement allows either side to end the engagement with 30 days’ written notice. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concentra Group Holdings Parent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002014596-26-000047), on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here